OBI Pharma
4174.TWO
| Exchange: | TWO |
| Currency | New Taiwan Dollar |
| ISIN: | TW0004174008 |
| Primary Ticker: | 4174.TWO |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Biotechnology |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Biotechnology |
| Gic Sub Industry: | Biotechnology |
| Description: | OBI Pharma, Inc., a biopharma company, develops and licenses novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally. It offers Adagloxad Simolenin (OBI-822), a breast cancer active immunity anti-cancer drug for generating antibody against tumor surface antigen Globo H; OBI-833, an immunity anti-cancer drug for the treatment of lung cancer; OBI-866 SSEA-4, an active immune-oncology drug; OBI-888, a Globo H monoclonal antibody; OBI-999, an antibody drug conjugate; OBI-3424, a micromolecule chemotherapy prodrug; and OBI-858, a botulinum toxin, as well as OBI-898, OBI-998, and COVID-19 BC Vax drugs. The company was founded in 2002 and is headquartered in Taipei, Taiwan. |
| Address: | No. 508, Sec. 7, Taipei, Taiwan, 115 |
| Website: | https://www.obipharma.com |
| Updated On: | 2024-11-04 |
Highlights
| Market Capitalization: | 15058899968 |
| Market Capitalization Mln: | 15058.9 |
| EBITDA: | -2063065984 |
| Book Value: | 12.52 |
| Earnings Share: | -9.35 |
| Most Recent Quarter: | 2024-06-30 |
| Operating Margin TTM: | -28.66 |
| Return On Assets TTM: | -0.25 |
| Return On Equity TTM: | -0.46 |
| Revenue TTM: | 58046000 |
| Revenue Per Share TTM: | 0.25 |
| Quarterly Revenue Growth YOY: | 0.92 |
| Gross Profit TTM: | -40144000 |
| Diluted Eps TTM: | -9.35 |
Valuation
| Price Sales TTM: | 259.43 |
| Price Book MRQ: | 5.35 |
| Enterprise Value: | 14044560101 |
| Enterprise Value Revenue: | 241.95 |
| Enterprise Value Ebitda: | -12.32 |
Shares
| Shares Outstanding: | 230611008 |
| Shares Float: | 166791675 |
| Percent Insiders: | 36.42 |
| Percent Institutions: | 4.85 |
Technicals
| Beta: | 0.89 |
| 52 Week High: | 92.9 |
| 52 Week Low: | 58 |
| 50 Day MA: | 74.75 |
| 200 Day MA: | 66.53 |
Earnings
| Report Date: | 2025-05-08 |
| Date: | 2025-03-31 |
| Before After Market: | After Market |
| Currency: | TWD |
| Report Date: | 2025-03-10 |
| Date: | 2024-12-31 |
| Before After Market: | After Market |
| Currency: | TWD |
| Report Date: | 2024-11-04 |
| Date: | 2024-09-30 |
| Before After Market: | After Market |
| Currency: | TWD |
| Report Date: | 2023-03-13 |
| Date: | 2022-12-31 |
| Before After Market: | After Market |
| Currency: | TWD |
| Eps Actual: | -2.52 |
| Report Date: | 2022-05-06 |
| Date: | 2022-03-31 |
| Before After Market: | After Market |
| Currency: | TWD |
| Eps Actual: | -1.52 |
| Report Date: | 2022-03-18 |
| Date: | 2021-12-31 |
| Before After Market: | After Market |
| Currency: | TWD |
| Eps Actual: | -2.81 |
| Report Date: | 2021-11-05 |
| Date: | 2021-09-30 |
| Before After Market: | After Market |
| Currency: | TWD |
| Eps Actual: | -1.62 |
| Report Date: | 2021-08-06 |
| Date: | 2021-06-30 |
| Before After Market: | After Market |
| Currency: | TWD |
| Eps Actual: | -2.06 |
| Report Date: | 2021-05-07 |
| Date: | 2021-03-31 |
| Before After Market: | After Market |
| Currency: | TWD |
| Eps Actual: | -1.14 |
| Report Date: | 2020-11-06 |
| Date: | 2020-09-30 |
| Before After Market: | After Market |
| Currency: | TWD |
| Eps Actual: | -1.99 |
| Report Date: | 2020-08-13 |
| Date: | 2020-06-30 |
| Before After Market: | After Market |
| Currency: | TWD |
| Eps Actual: | -1.65 |
| Report Date: | 2020-05-14 |
| Date: | 2020-03-31 |
| Before After Market: | After Market |
| Currency: | TWD |
| Eps Actual: | -1.67 |
| Eps Estimate: | -1.13 |
| Eps Difference: | -0.54 |
| Surprise Percent: | -47.78 |
| Report Date: | 2020-03-13 |
| Date: | 2019-12-31 |
| Before After Market: | After Market |
| Currency: | TWD |
| Eps Actual: | -2.75 |
| Eps Estimate: | -1.94 |
| Eps Difference: | -0.81 |
| Surprise Percent: | -41.75 |
| Report Date: | 2018-11-15 |
| Date: | 2018-09-30 |
| Before After Market: | Before Market |
| Currency: | TWD |
| Eps Actual: | -2.37 |
| Report Date: | 2018-08-14 |
| Date: | 2018-06-30 |
| Before After Market: | Before Market |
| Currency: | TWD |
| Eps Actual: | -0.8 |
| Report Date: | 2018-05-15 |
| Date: | 2018-03-31 |
| Before After Market: | After Market |
| Currency: | TWD |
| Eps Actual: | -1.5 |
| Eps Estimate: | -1.66 |
| Eps Difference: | 0.16 |
| Surprise Percent: | 9.63 |
| Report Date: | 2018-03-12 |
| Date: | 2017-12-31 |
| Before After Market: | After Market |
| Currency: | TWD |
| Eps Actual: | -2.07 |
| Eps Estimate: | -1.96 |
| Eps Difference: | -0.11 |
| Surprise Percent: | -5.61 |
| Report Date: | 2017-11-14 |
| Date: | 2017-09-30 |
| Before After Market: | After Market |
| Currency: | TWD |
| Eps Actual: | -1.95 |
| Eps Estimate: | -1.75 |
| Eps Difference: | -0.2 |
| Surprise Percent: | -11.42 |
| Report Date: | 2017-08-14 |
| Date: | 2017-06-30 |
| Before After Market: | After Market |
| Currency: | TWD |
| Eps Actual: | -1.62 |
| Eps Estimate: | -1.32 |
| Eps Difference: | -0.3 |
| Surprise Percent: | -22.72 |
| Report Date: | 2016-11-14 |
| Date: | 2016-09-30 |
| Before After Market: | After Market |
| Currency: | TWD |
| Eps Actual: | -2.16 |
| Eps Estimate: | -1.2 |
| Eps Difference: | -0.96 |
| Surprise Percent: | -8 |
| Report Date: | 2016-08-15 |
| Date: | 2016-06-30 |
| Before After Market: | After Market |
| Currency: | TWD |
| Eps Actual: | -0.69 |
| Eps Estimate: | -1.3 |
| Eps Difference: | 0.61 |
| Surprise Percent: | 46.92 |
| Report Date: | 2016-05-16 |
| Date: | 2016-03-31 |
| Before After Market: | After Market |
| Currency: | TWD |
| Eps Actual: | -2.04 |
| Eps Estimate: | -0.86 |
| Eps Difference: | -1.18 |
| Surprise Percent: | -137.20 |
| Report Date: | 2016-03-25 |
| Date: | 2015-12-31 |
| Before After Market: | After Market |
| Currency: | TWD |
| Eps Actual: | -1.53 |
| Eps Estimate: | -0.19 |
| Eps Difference: | -1.34 |
| Surprise Percent: | -705.26 |
| Report Date: | 2015-05-13 |
| Date: | 2015-03-31 |
| Before After Market: | After Market |
| Currency: | TWD |
| Eps Actual: | -2.43 |
| Eps Estimate: | -0.99 |
| Eps Difference: | -1.44 |
| Surprise Percent: | -145.45 |
| Date: | 2019-12-31 |
| Period: | +1y |
| Eps Trend7days Ago: | -10.03 |
| Eps Trend30days Ago: | -10.03 |
| Eps Trend60days Ago: | -10.03 |
| Eps Trend90days Ago: | -10.03 |
| Date: | 2018-12-31 |
| Revenue Estimate Number Of Analysts: | 1.00 |
| Eps Trend7days Ago: | -9.17 |
| Eps Trend30days Ago: | -9.17 |
| Eps Trend60days Ago: | -9.17 |
| Eps Trend90days Ago: | -9.17 |
| Date: | 2018-09-30 |
| Period: | +1q |
| Earnings Estimate Year Ago Eps: | -1.97 |
| Revenue Estimate Avg: | 315000.00 |
| Revenue Estimate Number Of Analysts: | 1.00 |
| Eps Trend7days Ago: | -2.06 |
| Eps Trend30days Ago: | -2.06 |
| Eps Trend60days Ago: | -2.06 |
| Eps Trend90days Ago: | -2.06 |
| Date: | 2018-06-30 |
| Earnings Estimate Year Ago Eps: | -1.64 |
| Revenue Estimate Avg: | 395000.00 |
| Revenue Estimate Number Of Analysts: | 1.00 |
| Eps Trend7days Ago: | -1.94 |
| Eps Trend30days Ago: | -1.94 |
| Eps Trend60days Ago: | -1.94 |
| Eps Trend90days Ago: | -1.94 |
| Date: | 2024-09-30 |
| Date: | 2022-12-31 |
| Eps Actual: | -4.0 |
| Date: | 2021-12-31 |
| Eps Actual: | -12.9 |
| Date: | 2019-12-31 |
| Eps Actual: | -7.4 |
| Date: | 2017-12-31 |
| Eps Actual: | -10.5 |
| Date: | 2015-12-31 |
| Eps Actual: | -3.9 |